The structure of pyruvate kinase from Leishmania mexicana reveals details of the allosteric transition and unusual effector specificity - PubMed (original) (raw)
Comparative Study
. 1999 Aug 20;291(3):615-35.
doi: 10.1006/jmbi.1999.2918.
Affiliations
- PMID: 10448041
- DOI: 10.1006/jmbi.1999.2918
Comparative Study
The structure of pyruvate kinase from Leishmania mexicana reveals details of the allosteric transition and unusual effector specificity
D J Rigden et al. J Mol Biol. 1999.
Erratum in
- J Mol Biol 1999 Oct 29;293(3):745-9
Abstract
Glycolysis occupies a central role in cellular metabolism, and is of particular importance for the catabolic production of ATP in protozoan parasites such as Leishmania and Trypanosoma. In these organisms pyruvate kinase plays a key regulatory role, and is unique in responding to fructose 2,6-bisphosphate as allosteric activator. The determination of the first eukaryotic pyruvate kinase crystal structure in the T-state is reported. A comparison of the leishmania and yeast R-state enzymes reveals fewer differences than the previous comparison of Escherichia coli T-state and rabbit muscle non-allosteric enzymes. Structural changes related to the allosteric transition can therefore be distinguished from those that are a consequence of the inherent wide structural divergence between bacterial and mammalian proteins. The allosteric transition involves significant changes in a tightly packed array of eight alpha helices at the interface near the catalytic site. At the other interface the allosteric transition appears to be accompanied by the bending of a ten-stranded intersubunit beta sheet adjacent to the effector site. Helix Calpha1 makes contacts to the N-terminal helical domain and bridges both interfaces. A comparison of the effector sites of the leishmania and yeast enzymes reveals the structural basis for the different effector specificity. Two loops comprising residues 443-453 and 480-489 adopt very different conformations in the two enzymes, and Lys453 and His480 that are a feature of trypanosomatid enzymes provide probable ligands for the 2-phospho group of the effector molecule. These differences offer an opportunity for the design of drugs that would bind to the trypanosomatid enzymes but not to those of the mammalian host.
Copyright 1998 Academic Press.
Similar articles
- Leishmania pyruvate kinase: the crystal structure reveals the structural basis of its unique regulatory properties.
Fothergill-Gillmore LA, Rigden DJ, Michels PA, Phillips SE. Fothergill-Gillmore LA, et al. Biochem Soc Trans. 2000 Feb;28(2):186-90. doi: 10.1042/bst0280186. Biochem Soc Trans. 2000. PMID: 10816124 - Cloning and sequence analysis of the gene encoding pyruvate kinase in Trypanoplasma borelli.
Ernest I, Opperdoes FR, Michels PA. Ernest I, et al. Biochem Biophys Res Commun. 1994 Jun 15;201(2):727-32. doi: 10.1006/bbrc.1994.1761. Biochem Biophys Res Commun. 1994. PMID: 8003008 - Allostery in rabbit pyruvate kinase: development of a strategy to elucidate the mechanism.
Friesen RH, Castellani RJ, Lee JC, Braun W. Friesen RH, et al. Biochemistry. 1998 Nov 3;37(44):15266-76. doi: 10.1021/bi981273y. Biochemistry. 1998. PMID: 9799487 - Structural basis of effector regulation and signal termination in heterotrimeric Galpha proteins.
Sprang SR, Chen Z, Du X. Sprang SR, et al. Adv Protein Chem. 2007;74:1-65. doi: 10.1016/S0065-3233(07)74001-9. Adv Protein Chem. 2007. PMID: 17854654 Review. - Allosteric mechanisms in ACT domain containing enzymes involved in amino acid metabolism.
Liberles JS, Thórólfsson M, Martínez A. Liberles JS, et al. Amino Acids. 2005 Feb;28(1):1-12. doi: 10.1007/s00726-004-0152-y. Epub 2005 Jan 18. Amino Acids. 2005. PMID: 15662561 Review.
Cited by
- The crystal structure of Toxoplasma gondii pyruvate kinase 1.
Bakszt R, Wernimont A, Allali-Hassani A, Mok MW, Hills T, Hui R, Pizarro JC. Bakszt R, et al. PLoS One. 2010 Sep 14;5(9):e12736. doi: 10.1371/journal.pone.0012736. PLoS One. 2010. PMID: 20856875 Free PMC article. - An improved strategy for the crystallization of Leishmania mexicana pyruvate kinase.
Morgan HP, McNae IW, Hsin KY, Michels PA, Fothergill-Gilmore LA, Walkinshaw MD. Morgan HP, et al. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Mar 1;66(Pt 3):215-8. doi: 10.1107/S1744309109053494. Epub 2010 Feb 23. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010. PMID: 20208146 Free PMC article. - What Mutagenesis Can and Cannot Reveal About Allostery.
Carlson GM, Fenton AW. Carlson GM, et al. Biophys J. 2016 May 10;110(9):1912-23. doi: 10.1016/j.bpj.2016.03.021. Biophys J. 2016. PMID: 27166800 Free PMC article. Review. - Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.
Zoraghi R, See RH, Axerio-Cilies P, Kumar NS, Gong H, Moreau A, Hsing M, Kaur S, Swayze RD, Worrall L, Amandoron E, Lian T, Jackson L, Jiang J, Thorson L, Labriere C, Foster L, Brunham RC, McMaster WR, Finlay BB, Strynadka NC, Cherkasov A, Young RN, Reiner NE. Zoraghi R, et al. Antimicrob Agents Chemother. 2011 May;55(5):2042-53. doi: 10.1128/AAC.01250-10. Epub 2011 Feb 28. Antimicrob Agents Chemother. 2011. PMID: 21357306 Free PMC article. - Sequence analysis and characterization of pyruvate kinase from Clonorchis sinensis, a 53.1-kDa homopentamer, implicated immune protective efficacy against clonorchiasis.
Chen T, Jiang H, Sun H, Xie Z, Ren P, Zhao L, Dong H, Shi M, Lv Z, Wu Z, Li X, Yu X, Huang Y, Xu J. Chen T, et al. Parasit Vectors. 2017 Nov 9;10(1):557. doi: 10.1186/s13071-017-2494-9. Parasit Vectors. 2017. PMID: 29121987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases